Learn
Explore our list of resources
Depending on your rare disease journey, Global Genes provides you with the resource and community to enhance your learning.
Featured
Gene-Based Diagnosis 101: How to Successfully Navigate the Diagnostic Journey
As scientific innovation in genomic medicine continues to provide more hope for therapeutic options, there is a […]
Read moreA Case for Whole Genome Sequencing
The ability to diagnose rare genetic diseases through the use of genetic sequencing has improved to a […]
Read moreAdvances in Rare Immunological Diseases
Recent advances in rare immunological diseases have raised the exciting potential of cures for some disorders. Hear […]
Read moreDevelopmental Delays After Factor V Leiden Pregnancy
by Tiffany Burnette I was diagnosed with Factor V Leiden when I was pregnant with Sammy. While […]
Read morePatient Stories
Living and Advocating Through a Complex Medical Journey: Erythromelalgia, Visual Snow Syndrome, and Autoimmune Dysregulation
Hello, my name is Sierra Domb. Since childhood, I have experienced Erythromelalgia (EM) and Autoimmune Dysregulation (AD). […]
Read moreLiving with Brugada Syndrome
Brugada is insidious, especially for someone my age. It tends to “hide” in the ECG. Many times, it looks normal… but it isn’t. And with the myocarditis I had at the same time, it was even harder to get a correct diagnosis. The doctors didn’t know whether the findings were due to Brugada or to myocarditis. After my hospitalization, and after I suffered a fainting episode, it was finally decided that I should be implanted with a defibrillator (ICD). When it happened, I felt like life was given back to me.
Read moreHe Is Three. His Voice Isn’t Lost —It’s Waiting to Be Heard.
By the time a genetic diagnosis of a rare mutation in the PPP3CA gene finally arrived, critical months — even years — had slipped away. Milestones were missed while we waited for answers. Early concerns were minimized, and our pleas for help were too often brushed aside until delays became severe. That delay is not just a bureaucratic failure; it is lost opportunity — lost time for therapies that could have helped him build strength, communication, and independence.
Read moreThe Beginning of Our Lowe Syndrome Journey
By Caroline Tsai The sun blazes overhead without a cloud in sight. Only a high of 90 […]
Read moreInvincible Never Invisible: A Decade of InvisiYouth
I was competitive tennis player as a teen and was unfortunately injured in training, which resulted in dealing with an injury and neurovascular condition that changed the trajectory of my life. I was thrust into the world of living with a chronic illness, years of trying to find proper diagnoses and treatments, all while balancing life as a teen/young adult. During this entire young adult experience, my doctors would tell me “wait” till they could fix my health to live my life fully… I created InvisiYouth out of my love of philanthropy, and my newfound passion to giving a voice for the young adult population living with all chronic illnesses and disabilities for the non-medical aspects of their lives with health struggles.
Read moreBeauty in Being Rare
Classical HCU is a condition in which my liver has a defective enzyme that is supposed to break down methionine. Instead, it builds up and turns into homocysteine, which is extremely toxic to your body. These elevated levels can result in blood clots, strokes, and other life-threatening complications. I follow an extremely restrictive low-protein diet—only about 10 grams of whole protein per day—alongside a methionine-free formula, the medication called betaine, and a cocktail of vitamins and supplements.
Read moreLatest News
Savara’s Early Access Program
Savara’s Early Access Program (EAP) for molgramostim inhalation solution (molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune […]
Read morePublication Announcement — RARE-X: Advancing Rare Disease Research Through Patient-Driven Data
Global Genes is excited to announce “RARE-X: A patient-driven approach for collecting symptom and patient-reported outcome data […]
Read moreAccelerating Rare Disease Research Through Collaboration: Global Genes and Notre Dame Launch the Research Acceleration Program
Global Genes and University of Notre Dame have partnered to launch the Research Acceleration Program, a collaborative […]
Read moreRARE Advocacy Exchange Session 8, Knowing Your Rare Rights
This session recording is from Oct. 16, 2025 Rare Advocacy Exchange Session 8: Knowing the Rights for […]
Read moreGlobal Genes Guide to Starting a Nonprofit Patient Advocacy Organization
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 7, Getting a Precise Genetic Diagnosis
This session recording is from Sept. 18, 2025 Rare Advocacy Exchange Session 7: Getting A Precise Diagnosis […]
Read moreIndustry News
PTC Therapeutics Withdraws FDA Resubmission for DMD
Rare Daily Staff PTC Therapeutics said it has withdrawn the new drug application resubmission for Translarna (ataluren) […]
Read moreUltragenyx Cuts 10 Percent of Staff as Part of Restructuring
Rare Daily Staff Ultragenyx said it has initiated a strategic restructuring plan that will eliminate 10 percent […]
Read moreBridgeBio Reports Positive Phase 3 Results for Oral Achondroplasia Therapy
Rare Daily Staff BridgeBio Pharma said its experimental oral drug, infigratinib, helped children with achondroplasia grow faster […]
Read moreChanging the Autoimmune Disease Playbook with RNA-Engineered CAR T Cells
Autoimmune diseases like myasthenia gravis have long forced patients to trade daily function for chronic immunosuppression, but […]
Read moreFDA Rejects Regenxbio’s MPS II Gene Therapy
Rare Daily Staff The U.S. Food and Drug Administration rejected Regenxbio’s application for accelerated approval of RGX-121, […]
Read moreOxford-Harrington Awards Nearly $900K in Friedreich’s Ataxia Grants
Rare Daily Staff The Oxford-Harrington Rare Disease Centre’s FA Alliance Innovation Fund has awarded funding to five […]
Read moreKingsmore Stepping Down from Rady Children’s Institute for Genomic Medicine
Rare Daily Staff Stephen Kingsmore, a pioneer in the clinical use of rapid whole genome sequencing, will […]
Read moreRewriting Rare Disease R&D with Foundation Models
Drug development has long been a costly, trial-and-error effort, with nine out of ten clinical programs failing […]
Read moreTrump Signs Legislation to Reauthorize PRV Program
Rare Daily Staff The Rare Pediatric Disease Priority Review Voucher program has been reauthorized through fiscal 2029 […]
Read moreGenetic Counseling
Global Genes Guide to Genetic Diagnosis
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes 2025 Quick Guide Series
We are excited to announce the launch of a new series of Quick Guides for the […]
Read moreAngelina Spreading Light, Love, and Inspiration on CASK Gene Awareness Day
To recognize CASK Gene Awareness Day on July 15, Global Genes reached out to Giovi Moschoudis, mother […]
Read moreTeam Wally Inspires During Fragile X Awareness Month
To recognize Fragile X Awareness Month in July, Global Genes reached out to National Fragile X Foundation, […]
Read moreFrom First Symptoms to Advocate for Transverse Myelitis
To recognize Transverse Myelitis Awareness Month in June, Global Genes reached out to The MOG Project, a […]
Read moreMoving from Awareness to Action after Sickle Cell Disease Diagnosis
Karen L. Proudford, Ph.D. is the President of Williams E. Proudford Sickle Cell Fund, Inc., and daughter […]
Read moreResearch Readiness
A Gene Editing Approach to Work Across Multiple Diseases
Rare Daily Staff Researchers at the Broad Institute have developed a new genome-editing strategy that could potentially […]
Read moreNIH Makes $14.4 Million Award to Launch Initiative to Bring WGS to Newborn Screening
NIH Makes $14.4 Million Award to Launch Initiative to Bring WGS to Newborn Screening Rare Daily Staff […]
Read moreNIH awards Baylor $15.6 million to fund two rare diseases consortia
NIH awards Baylor $15.6 Million to Fund Two Rare Diseases Consortia Rare Daily Staff The National Institutes […]
Read moreNIH launches $50 Million Autism Data Science Initiative
Rare Daily Staff The National Institutes of Health has launched the Autism Data Science Initiative, a $50 […]
Read moreNIH Awards $8.6 Million Grant to Study Neurodevelopmental Conditions
Rare Daily Staff The National Institutes of Health awarded Mustafa Sahin, neurologist-in-chief and chair of the Department […]
Read moreNCATS Launches Challenge to Spotlight Rare Disease Research
Rare Daily Staff The National Center for Advancing Translational Sciences announced the launch of its 2025-2026 Rare […]
Read moreMental Health & Wellness
RARE Advocacy Exchange Session 6 : Grieving a RARE Diagnosis
Rare disease grief differs from the grief we commonly associate with losing a loved one to death. […]
Read moreA Student’s Perspective: Lessons from the 2025 RARE Drug Development Symposium
During my first week as a Harvard College junior, I was delighted to be given the opportunity […]
Read moreGlobal Genes Guide to Securing a State Proclamation for Rare Disease Awareness
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Your Rare Rights
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Fundraising
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Comprehensive Fundraising Strategic Documents
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 5 : Interacting with FDA: PFDD and Listening Sessions
If your rare disease is likely to have a clinical trial for a drug or treatment come […]
Read moreA PAG Leader Guide to Presenting the Patient Experience at Your EL-PFDD Session with the FDA.
A Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreLove, Advocacy, and Belonging: Reflections from a Rare Disease Ally
By Nicole Boice, Chief Mission Officer, Global Genes As Chief Mission Officer at Global Genes—and as the […]
Read moreRARE Daily
Seeing Perseverance through a New Lens
Rare Daily Staff The short film Ho’omao tells the story of Joey, a retired firefighter and law […]
Read moreUltragenyx Reports Positive Longer-Term Data for MPS IIIA Gene Therapy as It Resubmits BLA to FDA
Rare Daily Staff Ultragenyx Pharmaceutical said new long-term data from clinical studies of its experimental gene therapy […]
Read moreSanofi’s Drug Meets Primary Endpoints in Type 3 Gaucher Disease Study
Sanofi said its experimental therapy venglustat met the primary and three of four key secondary endpoints in […]
Read moreQuince Stock Tumbles and Board Members Resign After Phase 3 Miss in A-T
Rare Daily Staff Quince Therapeutics said its lead experimental therapy failed to meet the primary and secondary […]
Read moreCIRM Approves $100 Million Plan to Accelerate Genetic Therapies for Rare Diseases
Rare Daily Staff The California Institute for Regenerative Medicine has approved a new funding program to accelerate […]
Read moreModerna Enters Strategic Collaboration with Recordati for Rare Metabolic Disorder
Rare Daily Staff Moderna said it entered into a strategic collaboration with Italy-based Recordati to advance Moderna’s […]
Read moreSearch the RARE List
For more resources, disease-specific information, and news, search our RARE List- an extensive list of rare diseases and rare conditions.
Search Our Full RARE List